Deutsche Bank AG Acquires 41,465 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Deutsche Bank AG grew its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,162,874 shares of the medical device company's stock after purchasing an additional 41,465 shares during the period. Deutsche Bank AG owned about 0.58% of Cooper Companies worth $106,903,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of COO. Barclays PLC raised its holdings in Cooper Companies by 0.7% in the third quarter. Barclays PLC now owns 462,947 shares of the medical device company's stock worth $51,082,000 after purchasing an additional 3,070 shares during the period. Franklin Resources Inc. raised its holdings in shares of Cooper Companies by 194.0% during the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company's stock worth $5,265,000 after acquiring an additional 32,260 shares during the period. Principal Financial Group Inc. raised its holdings in shares of Cooper Companies by 6.6% during the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company's stock worth $26,295,000 after acquiring an additional 14,687 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock worth $543,979,000 after acquiring an additional 573,908 shares during the period. Finally, Fulton Bank N.A. raised its holdings in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock worth $342,000 after acquiring an additional 109 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

Shares of COO traded down $2.68 during trading hours on Tuesday, hitting $81.76. The company's stock had a trading volume of 1,568,444 shares, compared to its average volume of 1,450,892. The company has a market cap of $16.35 billion, a price-to-earnings ratio of 41.93, a PEG ratio of 2.25 and a beta of 1.08. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The business has a 50 day simple moving average of $80.22 and a two-hundred day simple moving average of $90.59. The Cooper Companies, Inc. has a 52-week low of $69.81 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. On average, equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Piper Sandler reiterated an "overweight" rating and issued a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Robert W. Baird cut their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Finally, Stifel Nicolaus cut their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.